Article Versions Notes

Tiu VE, Popescu BO, Enache II, Tiu C, Terecoasa E, Panea CA. Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis. Diagnostics. 2022; 12(11):2571. https://doi.org/10.3390/diagnostics12112571

Tiu, Vlad Eugen, Bogdan Ovidiu Popescu, Iulian Ion Enache, Cristina Tiu, Elena Terecoasa, and Cristina Aura Panea. 2022. "Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis" Diagnostics 12, no. 11: 2571. https://doi.org/10.3390/diagnostics12112571

Tiu, V. E., Popescu, B. O., Enache, I. I., Tiu, C., Terecoasa, E., & Panea, C. A. (2022). Serum and CSF Biomarkers Predict Active Early Cognitive Decline Rather Than Established Cognitive Impairment at the Moment of RRMS Diagnosis. Diagnostics, 12(11), 2571. https://doi.org/10.3390/diagnostics12112571